在瘤微环境的重建3D细胞模型中评估基于抗体的新型疗法
Giacomo Domenici1,2, Nuno F Lopes1,2, Gonçalo Trindade1,2
1iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, Oeiras, 2780-901, Portugal.
Advanced biology
|November 27, 2024
概括
一个新的3D乳腺癌模型 (3D-3) 有效模拟瘤微环境 (TME). 该模型准确评估抗体-药物合物 (ADC) 和针对瘤和免疫细胞的免疫调节抗体.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物材料科学 生物材料科学
背景情况:
- 针对性疗法,如抗体药物合物 (ADC) 和免疫调节抗体 (Abs),对于癌症治疗至关重要.
- 评估这些疗法需要模拟复杂瘤微环境 (TME) 的临床前模型.
研究的目的:
- 开发一个3D乳腺癌细胞模型 (3D-3) 总结TME的关键特征.
- 评估3D-3模型对评估基于抗体的治疗方法的有用性.
主要方法:
- 使用酸盐和基于化的培养的微封装策略被用于创建3D-3模型.
- 流体 (癌症相关纤维细胞 - CAF) 和免疫 (瘤相关巨细胞 - TAM) 组件被纳入多细胞瘤球体.
- 该模型的疗效使用抗HER2抗体-药物合物 (ADC) 和阻断抗体的殖民地刺激因子1受体 (CSF1R) 进行了测试.
主要成果:
- ADCs证明了针对HER2+乳腺癌球体的瘤细胞特异性细胞毒性,节省了HER2-阴性CAFs.
- 阻断CSF1R的抗体减少了TAM中的免疫抑制标记物,反映了体内观察.
- 3D-3模型成功模拟了癌细胞,CAF和TAM之间的相互作用.
结论:
- 基于人类TME的3D-3细胞模型是评估基于抗体的新疗法的宝贵工具.
- 该模型可以评估针对TME内的癌细胞和巨细胞的治疗方法的抗瘤和免疫调节潜力.
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


